1. Wondemagegnehu E, World Health Organization. Counterfeit and substandard drugs in Myanmar and Viet Nam. 1999.
http://apps.who.int/medicinedocs/pdf/s2276e/s2276e.pdf
. Accessed 05 Oct 2014; World Health Organization. Counterfeit and substandard drugs in Myanmar and Viet Nam. Geneva. 1999.
http://apps.who.int/medicinedocs/pdf/s2276e/s2276e.pdf
. Accessed 30 Sept 2014.
2. Worthen D. The pharmaceutical industry, 1952–2002. J Am Pharm Assoc. 2002;42:683–6.
3. Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, et al. How to achieve international action on falsified and substandard medicines. Br Med J. 2012;345:e7381.
4. The Institute of Medicine. Countering the problem of falsified and substandard drugs. 2013.
http://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx
. Accessed 01 Oct 2014.
5. Bate R, Jensen P, Hess K, Mooney L, Milligan J. Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis. 2013;17:308–11.